Roche bets up to $1B to expand Dyno gene therapy delivery pact
25 Oct 2024 //
FIERCE BIOTECH
Dyno To Use NVIDIA AI For Biological Sequence Design
09 May 2024 //
BUSINESSWIRE
Dyno Gene Delivery Cost Reduction Path At ASGCT 2024
09 May 2024 //
BUSINESSWIRE
Dyno to Present AAV Capsid AI Design at ASGCT and SynBioBeta
23 Apr 2024 //
BUSINESSWIRE
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product
19 May 2023 //
BUSINESSWIRE
Dyno to Present New Data on Optimized AAV Capsids with Transformative (ASGCT)
02 May 2023 //
BUSINESSWIRE
Insulin price, Astellas, Fujifilm and more—Fierce Pharma Asia
03 Dec 2021 //
FIERCEPHARMA
With only burns to show in gene therapy, Astellas inks deal AAV specialist Dyno
02 Dec 2021 //
ENDPTS
Astellas inks $1.6B pact with Dyno to continue gene therapy play
01 Dec 2021 //
FIERCEBIOTECH
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning
11 May 2021 //
BUSINESSWIRE
Dyno Closes $100 Million Series A Financing Led by Andreessen Horowitz
06 May 2021 //
BUSINESSWIRE
Dyno raises $100 million to bring artificial intelligence to gene therapy
06 May 2021 //
STATNEWS
Dyno`s Eric Kelsic fills the tank in his quest for better AAV with a group
06 May 2021 //
ENDPTS
Dyno grabs $100M to expand tech, ink more gene therapy deals
06 May 2021 //
FIERCEBIOTECH
Dyno, in demand for its gene therapy work, raises $100M for fast expansion
05 May 2021 //
BIOPHARMADIVE
Dyno Announces Presentations at 2021 American Society of Gene and Cell Therapy
27 Apr 2021 //
BUSINESSWIRE
Dyno Announces Publication in Nature Biotechnology Use of Artificial
11 Feb 2021 //
BUSINESSWIRE
Dyno sketches tens of thousands of viable next-gen AAV capsids
11 Feb 2021 //
ENDPTS
Roche`s James Sabry inks his 2nd AI deal back-to-back pacts partnering Genentech
19 Oct 2020 //
ENDPTS
Roche partners with Dyno Therapeutics on AAV vectors for gene therapies
14 Oct 2020 //
PRESS RELEASE